Recall of Ventolin (Albuterol) by GSK. If your Albuterol is name brand Ventolin then please check to make sure it is not recalled. The affected lot numbers are 6ZP0003, 6ZP9944 and 6ZP9848. Contact GSK’s customer service center at 1-888-825-5249 with questions.
There has been a recall of Epipen and Epipen Jr.
These are pens that expire in April, May, September and October.
Please check your pens at www.mylan.com/epipenrecall
Xolair is approved down to the age of 12 years old for the treatment of Chronic Idiopathic Urticaria (Chronic Hives). So if taking antihistamines is not providing complete relief or the side effects of antihistamines is too much to handle then this may the relief you are looking for. It’s a once a month injection under your skin (on the back of your arms). It’s a unique treatment given by your allergist.
Starting January 2017, we will be extending Tuesday afternoon shot hours from ending at 4:30pm til 4:55 pm by appt. Any patient coming in after 4:30pm should call the office ahead of time and make an appointment.
For infants under the age of 12months, if they are at high risk (+family history of peanut allergy; eczema, allergies), we are offering early introduction protocol in order to prevent them from developing a peanut allergy.
Based on the LEAP Study, regular feeding of peanut protein to children at high risk can significantly reduce the development of peanut allergy.
Make an appt for your at risk infant to be evaluated for a peanut allergy, prior to starting the introduction.
For our patients who liked the Auvi Q, it is set to return to the market February 14, 2017 and will be free to most patients with commercial insurance.
Call our office to request a prescription. If you have not been seen in the past 12 months then schedule an appointment asap.
New peanut study is about to begin at the Johns Hopkins and are enrolling adult (18 yrs to 50 yrs old) patients only with peanut allergy. If interested,contact Kim Mudd at KMudd2@jhmi.edu
In phase 3 trials is the new peanut patch therapy. We are closely following its develop as it appears that it may be available to prescribe in the next few years. We are still awaiting for guidelines for this new therapy.
As we get underway with signing off on school forms, we are often asked about the Epipen dosing. The appropriate dosing is 0.01mg/kg however the devices (Epipen and Auvi Q) only come in 2 set doses, Jr 0.15mg and Regular 0.3mg. If your child have a severe food allergy or a nut allergy, once your child’s weight is 44lbs (20kg), we recommend moving your child up to the next dose from the Jr to regular as underdosing can lead to fatality. The increased dose may cause some transient side effects such as increased heart rate and jitteriness.
Exciting new study from England, LEAP study has shown that early introduction of peanuts (2 grams, about 8 peanuts) starting in infancy on a regular basis (3 times a week for 5 years) may be able to prevent the onset of peanut allergy for those at risk of developing a peanut allergy. The study was the first of it’s kind. Many more studies are needed to answer the numerous questions that have risen but it is a promising method that we are implementing in our practice. Recommend patients come in between 4 months and 10 months of age.
Dr. Bailey discussed this on a panel with the LEAP research physicians from London on the Diane Rehm Show WAMU 88.5FM.